Literature DB >> 20081672

Should care homes adopt a static-led approach to pressure ulcer prevention?

Delia Catherine Keen1.   

Abstract

A static-led approach refers to the provision of high-specification foam mattresses for the whole of a population at risk of pressure damage. Such mattresses have been found to reduce the risk of pressure ulceration and cost less overall than standard mattresses, even in populations where only 1 in 100 patients develops a pressure ulcer. Reduced pressure ulcer prevalence and reduced costs resulting from decreased expenditure on dynamic mattresses following the implementation of a static-led approach have been reported. Pressure ulcers cause pain, a reduced quality of life, loss of independence, depression and social isolation for those in whom they develop. Organizations are increasingly having to pay out large sums of money following litigation surrounding pressure ulcers. This article explains why NHS healthcare providers and private care organizations need to work together to consider implementing a static-led approach to pressure ulcer prevention within care homes in order to reduce pressure ulcer incidence cost-effectively within their local populations.

Entities:  

Mesh:

Year:  2009        PMID: 20081672     DOI: 10.12968/bjon.2009.18.sup7.45130

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  2 in total

1.  Multicenter comparison of the efficacy on prevention of pressure ulcer in postoperative patients between two types of pressure-relieving mattresses in China.

Authors:  Qixia Jiang; Xiaohua Li; Aiqin Zhang; Yanxia Guo; Yahong Liu; Haiying Liu; Xiaolong Qu; Yajun Zhu; Xiujun Guo; Li Liu; Liyan Zhang; Suping Bo; Jing Jia; Yuejuan Chen; Rui Zhang; Jiandong Wang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

2.  Preventing pressure injury in nursing homes: developing a care bundle using the Behaviour Change Wheel.

Authors:  Jacqueline F Lavallée; Trish A Gray; Jo C Dumville; Nicky Cullum
Journal:  BMJ Open       Date:  2019-06-03       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.